News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
677,144 Results
Type
Article (34645)
Company Profile (710)
Press Release (641781)
Multimedia
Podcasts (102)
Webinars (22)
Section
Business (197543)
Career Advice (2155)
Deals (36311)
Drug Delivery (136)
Drug Development (78009)
Employer Resources (164)
FDA (15485)
Job Trends (14791)
News (333147)
Policy (28997)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (4)
Academia (1353)
Academic (1)
Accelerated approval (42)
Adcomms (20)
Allergies (164)
Alliances (46910)
ALS (200)
Alzheimer's disease (1675)
Antibody-drug conjugate (ADC) (423)
Approvals (15805)
Artificial intelligence (620)
Autoimmune disease (256)
Automation (45)
Bankruptcy (377)
Best Places to Work (10894)
BIOSECURE Act (23)
Biosimilars (204)
Biotechnology (439)
Bladder cancer (165)
Brain cancer (64)
Breast cancer (625)
Cancer (5235)
Cardiovascular disease (441)
Career advice (1808)
Career pathing (43)
CAR-T (303)
CDC (29)
Celiac Disease (1)
Cell therapy (828)
Cervical cancer (39)
Clinical research (68060)
Collaboration (2026)
Company closure (6)
Compensation (1330)
Complete response letters (92)
COVID-19 (2326)
CRISPR (100)
C-suite (1101)
Cystic fibrosis (149)
Data (7173)
Decentralized trials (3)
Denatured (9)
Depression (164)
Dermatology (59)
Diabetes (518)
Diagnostics (6797)
Digital health (51)
Diversity (6)
Diversity, equity & inclusion (38)
Drug discovery (302)
Drug pricing (203)
Drug shortages (29)
Duchenne muscular dystrophy (267)
Earnings (87727)
Editorial (64)
Employer branding (24)
Employer resources (145)
Events (116262)
Executive appointments (1094)
FDA (18937)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (12)
Frontotemporal dementia (32)
Funding (1621)
Gene editing (221)
Generative AI (58)
Gene therapy (669)
GLP-1 (1046)
Government (3217)
Grass and pollen (8)
Guidances (388)
Healthcare (16252)
HIV (72)
Huntington's disease (55)
IgA nephropathy (94)
Immunology and inflammation (294)
Immuno-oncology (94)
Indications (161)
Infectious disease (2650)
Inflammatory bowel disease (206)
Inflation Reduction Act (13)
Influenza (132)
Intellectual property (282)
Interviews (432)
IPO (17347)
IRA (50)
Job creations (4223)
Job search strategy (1471)
JPM (62)
Kidney cancer (16)
Labor market (92)
Layoffs (642)
Leadership (41)
Legal (7212)
Liver cancer (94)
Longevity (25)
Lung cancer (688)
Lymphoma (379)
Machine learning (54)
Management (59)
Manufacturing (990)
MASH (186)
Medical device (14024)
Medtech (14113)
Mergers & acquisitions (20167)
Metabolic disorders (1423)
mRNA (195)
Multiple sclerosis (181)
NASH (19)
Neurodegenerative disease (396)
Neuropsychiatric disorders (113)
Neuroscience (3136)
Neurotech (1)
NextGen: Class of 2026 (6030)
Non-profit (2096)
Now hiring (76)
Obesity (683)
Opinion (315)
Ovarian cancer (186)
Pain (238)
Pancreatic cancer (275)
Parkinson's disease (342)
Partnered (33)
Patents (574)
Patient recruitment (641)
Peanut (63)
People (58904)
Pharmaceutical (127)
Pharmacy benefit managers (30)
Phase 1 (21489)
Phase 2 (30427)
Phase 3 (22410)
Pipeline (7538)
Policy (293)
Postmarket research (1915)
Preclinical (8691)
Press Release (64)
Prostate cancer (275)
Psychedelics (58)
Radiopharmaceuticals (332)
Rare diseases (1031)
Real estate (5780)
Recruiting (69)
Regulatory (23471)
Reports (44)
Research institute (1375)
Resumes & cover letters (339)
Rett syndrome (31)
RNA editing (19)
RSV (87)
Schizophrenia (176)
Series A (292)
Series B (217)
Service/supplier (26)
Sickle cell disease (107)
Special edition (28)
Spinal muscular atrophy (165)
Sponsored (32)
Startups (3932)
State (2)
Stomach cancer (17)
Supply chain (119)
Tariffs (99)
The Weekly (91)
Vaccines (1018)
Venture capital (110)
Weight loss (458)
Women's health (101)
Worklife (23)
Date
Last 7 days (748)
Last 30 days (2464)
Last 365 days (30329)
2026 (9823)
2025 (30369)
2024 (35509)
2023 (40264)
2022 (50449)
2021 (53656)
2020 (50724)
2019 (42165)
2018 (32209)
2017 (32383)
2016 (30646)
2015 (36058)
2014 (28701)
2013 (23601)
2012 (25172)
2011 (25363)
2010 (23245)
Location
Africa (692)
Alabama (98)
Alaska (6)
Arizona (254)
Arkansas (13)
Asia (41648)
Australia (6820)
California (12691)
Canada (3585)
China (1327)
Colorado (535)
Connecticut (557)
Delaware (355)
Europe (91643)
Florida (1825)
Georgia (393)
Hawaii (4)
Idaho (59)
Illinois (879)
India (93)
Indiana (602)
Iowa (24)
Japan (477)
Kansas (124)
Kentucky (47)
Louisiana (31)
Maine (80)
Maryland (1358)
Massachusetts (9284)
Michigan (357)
Minnesota (696)
Mississippi (5)
Missouri (142)
Montana (35)
Nebraska (26)
Nevada (136)
New Hampshire (87)
New Jersey (3337)
New Mexico (31)
New York (3258)
North Carolina (1690)
North Dakota (8)
Northern California (6332)
Ohio (348)
Oklahoma (21)
Oregon (47)
Pennsylvania (2505)
Puerto Rico (28)
Rhode Island (50)
South America (1080)
South Carolina (83)
South Dakota (1)
Southern California (4886)
Tennessee (166)
Texas (1963)
United States (44402)
Utah (361)
Vermont (1)
Virginia (289)
Washington D.C. (76)
Washington State (1031)
West Virginia (4)
Wisconsin (122)
Wyoming (2)
677,144 Results for "ert parent company".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Spruce Biosciences Announces Positive Type B Meetings with U.S. FDA for TA-ERT for the Treatment of Sanfilippo Syndrome Type B (MPS IIIB)
February 18, 2026
·
8 min read
Press Releases
Nemysis Limited Announces Investment by Kolinpharma Through Its Parent Company IGEA Holding S.p.A.
November 14, 2025
·
2 min read
Press Releases
Parent Project Muscular Dystrophy, Foundation to Eradicate Duchenne Announce 2026 Advocacy Leadership Awards Recipients Honoring Bipartisan Champions in Congress
March 9, 2026
·
3 min read
Press Releases
Spruce Biosciences Receives U.S. FDA Breakthrough Therapy Designation for Tralesinidase Alfa Enzyme Replacement Therapy (TA-ERT) in Sanfilippo Syndrome Type B (MPS IIIB)
October 7, 2025
·
6 min read
Press Releases
Capricor Therapeutics and Parent Project Muscular Dystrophy to Host Webinar Highlighting Positive Phase 3 HOPE-3 Topline Results in Duchenne Muscular Dystrophy
December 17, 2025
·
4 min read
Press Releases
RSV a Leading Cause of Infant Hospitalizations - Yet Few Parents Know About Protection Options
September 30, 2025
·
2 min read
Press Releases
Spruce Biosciences Announces Integrated Long-Term Clinical Data of Tralesinidase Alfa Enzyme Replacement Therapy (TA-ERT) Demonstrating Profound and Durable Efficacy and Safety in Patients with Sanfilippo Syndrome Type B (MPS IIIB)
August 15, 2025
·
9 min read
Press Releases
Capricor Therapeutics and Parent Project Muscular Dystrophy to Host Webinar to Review Latest Developments in the Deramiocel Program for the Treatment of Duchenne Muscular Dystrophy
July 29, 2025
·
4 min read
Job Trends
11 companies hiring in Illinois now
Looking for a biopharma job in Illinois? Check out the
BioSpace
list of 11 companies hiring life sciences professionals like you.
April 23, 2026
·
2 min read
·
Angela Gabriel
Press Releases
Sialidosis Market Expected to Exhibit a CAGR of 7.4% during 2025-2035, Impelled by Research and Development in Enzyme Replacement Therapies (ERT)
February 19, 2025
·
8 min read
1 of 67,715
Next
